Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CONRAY 43 DIN 00477095

Status: Cancelled Post Market
Holder: LIEBEL-FLARSHEIM CANADA INC
Molecule: IOTHALAMATE MEGLUMINE

Health Canada record

Active ingredient(s)IOTHALAMATE MEGLUMINE 430 MG
Dosage formSolution
RouteIntravascular
ScheduleETHICAL
ClassHuman
ATCV08AA04 IOTALAMIC ACID
Original market date31-Dec-1980
Current status date07-May-2018
SourceHealth Canada DPD

Establishment licence of the holder

Liebel-Flarsheim Canada Inc. — licence 102249, not currently licensed, last inspection rating C (2023-11-06).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing IOTHALAMATE MEGLUMINE

DINProductCompanyFormStrengthStatus
00223107CONRAY 30LIEBEL-FLARSHEIM CANADA INCSolutionIOTHALAMATE MEGLUMINE 300 MGCancelled Post Market
00131237CONRAY 60LIEBEL-FLARSHEIM COMPANY LLCSolutionIOTHALAMATE MEGLUMINE 600 MGCancelled Post Market
00274194CYSTO CONRAY INJ 43%MALLINCKRODT CANADA INC.LiquidIOTHALAMATE MEGLUMINE 430 MGCancelled Post Market
00397466CYSTO-CONRAY IILIEBEL-FLARSHEIM COMPANY LLCSolutionIOTHALAMATE MEGLUMINE 172 MGCancelled Post Market
00131628VASCORAYTYCO HEALTHCARESolutionIOTHALAMATE MEGLUMINE 520 MG; IOTHALAMATE SODIUM 260 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
165212015-01-13New Drug Submission (NDS)TRANSFER OF DRUG IDENTIFICATION NUMBERS
139182012-11-30New Drug Submission (NDS)Manufacturer name change
6762002-07-02New Drug Submission (NDS)MANUFACTURER NAME CHANGE
Request a quote for CONRAY 43

How to read a Canadian DIN record